Literature DB >> 25368222

NOTCH signaling roles in acute myeloid leukemia cell growth and interaction with other stemness-related signals.

Shuji Tohda1.   

Abstract

NOTCH activation plays oncogenic roles in acute T-lymphoblastic leukaemia (T-ALL). However, whether NOTCH is oncogenic or tumor-suppressive in acute myeloid leukaemia (AML) is still controversial. Herein, the roles of NOTCH in AML are reviewed. AML cells express NOTCH and NOTCH ligands; however, cell-autonomous activation is not observed. Activating NOTCH1 mutations are rare in AML, unlike in T-ALL. NOTCH ligand stimulation generally suppresses the in vitro growth of AML cells but promotes transient growth of some samples. Conversely, knockdown of NOTCH1 and NOTCH2 does not affect the growth of AML cells, whereas it suppresses the growth of T-ALL cells. These findings suggest that NOTCH is dispensable or suppressive for AML cell growth. However, the effects of NOTCH differ depending on cell conditions, and various stemness-related signals modify these effects; hence, forced NOTCH activation in vitro may not exhibit effects in bone marrow. Thus, further understanding is required for the development of AML therapies targeting NOTCH signalling. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Acute myeloid leukaemia; HEDGEHOG; JAGGED; NOTCH; WNT; review

Mesh:

Substances:

Year:  2014        PMID: 25368222

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.

Authors:  Jin Zhang; Wenqiang Sun; Xiangmudong Kong; Yanhong Zhang; Hee Jung Yang; Cong Ren; Yuqian Jiang; Mingyi Chen; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

Review 2.  The CSL proteins, versatile transcription factors and context dependent corepressors of the notch signaling pathway.

Authors:  Humberto Contreras-Cornejo; Germán Saucedo-Correa; Javier Oviedo-Boyso; Juan José Valdez-Alarcón; Víctor Manuel Baizabal-Aguirre; Marcos Cajero-Juárez; Alejandro Bravo-Patiño
Journal:  Cell Div       Date:  2016-09-27       Impact factor: 5.130

Review 3.  miRNAs in acute myeloid leukemia.

Authors:  Qiong Liao; Bingping Wang; Xia Li; Guosheng Jiang
Journal:  Oncotarget       Date:  2017-01-10

Review 4.  Targeting acute myeloid leukemia stem cell signaling by natural products.

Authors:  Kodappully Sivaraman Siveen; Shahab Uddin; Ramzi M Mohammad
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

5.  NOTCH-1 Gene Mutations Influence Survival in Acute Myeloid Leukemia Patients.

Authors:  Salah Aref; Rasha Rizk; Mohamed El Agder; Wafaa Fakhry; Maha El Zafarany; Mohamed Sabry
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

6.  Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.

Authors:  Shuangnian Xu; Xi Li; Jianmin Zhang; Jieping Chen
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 7.  Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.

Authors:  Ramin Radpour
Journal:  World J Stem Cells       Date:  2017-10-26       Impact factor: 5.326

8.  NOTCH activation promotes glycosyltransferase expression in human myeloid leukemia cells.

Authors:  Shichun Wang; Mai Itoh; Erika Shiratori; Mika Ohtaka; Shuji Tohda
Journal:  Hematol Rep       Date:  2018-09-24

9.  NKL homeobox gene activities in normal and malignant myeloid cells.

Authors:  Stefan Nagel; Michaela Scherr; Roderick A F MacLeod; Claudia Pommerenke; Max Koeppel; Corinna Meyer; Maren Kaufmann; Iris Dallmann; Hans G Drexler
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.